慢性肾脏病患者肾性贫血铁调素及其调控机制研究进展(4)
[23] Semenza GL.HIF-1：mediator of physiological and pathophysiological responses to hypoxia[J].J Appl Physiol(1985)，2000，88(4)：1474-1480.
[24] Liu Q，Davidoff O，Niss K，et al.Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis[J].J Clin Invest，2012，122(12)：4635-4644.
[25] Nai A，Lidonnici MR，Rausa M，et al.The second transferrin receptor regulates red blood cell production in mice[J].Blood，2015，125(7)：1170-1179.
[26] Nai A，Rubio A，Campanella A，et al.Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice[J].Blood，2016，127(19)：2327-2336.
[27] Zhao N，Nizzi CP，Anderson SA，et al.Low intracellular iron increases the stability of matriptase-2[J].J Biol Chem，2015，290(7)：4432-4446.
[28] Wagner M，Damien R，Caroline Kurtz A，et al.Hepcidin-25 diabetic chronic kidney disease is predictive for mortality an progression to end stage renal disease[J].PLoS One，2015，10 (4)：e0123072.
(收稿日期：2018-12-22 修回日期：2019-01-15)
(編辑：潘明志), 百拇医药(马瑞莺 王洁)
[24] Liu Q，Davidoff O，Niss K，et al.Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis[J].J Clin Invest，2012，122(12)：4635-4644.
[25] Nai A，Lidonnici MR，Rausa M，et al.The second transferrin receptor regulates red blood cell production in mice[J].Blood，2015，125(7)：1170-1179.
[26] Nai A，Rubio A，Campanella A，et al.Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice[J].Blood，2016，127(19)：2327-2336.
[27] Zhao N，Nizzi CP，Anderson SA，et al.Low intracellular iron increases the stability of matriptase-2[J].J Biol Chem，2015，290(7)：4432-4446.
[28] Wagner M，Damien R，Caroline Kurtz A，et al.Hepcidin-25 diabetic chronic kidney disease is predictive for mortality an progression to end stage renal disease[J].PLoS One，2015，10 (4)：e0123072.
(收稿日期：2018-12-22 修回日期：2019-01-15)
(編辑：潘明志), 百拇医药(马瑞莺 王洁)